References
1. Park SH, Lee SM. Evidence-based decision-making and health technology assessment in South Korea. Value Health 2008. 11Suppl 1. S163–S164.
2. Lee SM. Evidence-based healthcare: seeking for the broken virtuous circle. J Korean Med Assoc 2009. 52532–535.
3. Stafinski T, McCabe CJ, Menon D. Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems. Pharmacoeconomics 2010. 28113–142.
4. Klemp M, Fronsdal KB, Facey K. HTAi Policy Forum. What principles should govern the use of managed entry agreements? Int J Technol Assess Health Care 2011. 2777–83.
5. Eden J, Wheatley B, McNeil B, Sox H. Knowing what works in health care: a roadmap for the nation 2008. Washington, DC: The National Academies Press; 280.
6. Park S. Risk-sharing agreement on the pricing and reimbursement of new drugs. Korean J Health Econ Policy 2010. 16125–153.
7. Organisation for Economic Co-operation and Development (OECD). Pharmaceutical pricing policies in a global market 2008. Paris: OECD; 215.
8. Park S, Park EJ, Ko SJ. Policy measures to enhance access to drugs for rare diseases 2010. Seoul: Korea Institute for Health and Social Affairs;
9. Olsen LA, Aisner D, McGinnis JM. The learning healthcare system: workshop summary 2007. Washington, DC: National Academies Press; 374.
10. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006. 3552085–2098.
11. Rubin RJ, Mendelson DN. Translating guidelines into policy. Clin J Am Soc Nephrol 2007. 2209–210.
12. Green Park Collaborative (GPC) [Internet]. Center for Medical Technology Policy c2008. cited 2011 Oct 20. Baltimore, MD: Center for Medical Technology Policy; Available from:
http://www.cmtpnet.org/gpc.
13. Carino T, Williams RD 2nd, Colbert AM, Bridger P. Medicare's coverage of colorectal cancer drugs: a case study in evidence development and policy. Health Aff (Millwood) 2006. 251231–1239.
14. Chalkidou K, Hoy A, Littlejohns P. Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research. J R Soc Med 2007. 100453–460.
16. Lexchin J. Coverage with evidence development for pharmaceuticals: a policy in evolution? Int J Health Serv 2011. 41337–354.
17. McCabe CJ, Stafinski T, Edlin R, Menon D. Banff AED Summit. Access with evidence development schemes: a framework for description and evaluation. Pharmacoeconomics 2010. 28143–152.
18. Boggild M, Palace J, Barton P, Ben-Shlomo Y, Bregenzer T, Dobson C, Gray R. Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator. BMJ 2009. 339b4677.
19. Raftery J. Multiple sclerosis risk sharing scheme: a costly failure. BMJ 2010. 340c1672.
20. Wlodarczyk JH, Cleland LG, Keogh AM, McNeil KD, Perl K, Weintraub RG, Williams TJ. Public funding of bosentan for the treatment of pulmonary artery hypertension in Australia: cost effectiveness and risk sharing. Pharmacoeconomics 2006. 24903–915.
21. Trueman P, Grainger DL, Downs KE. Coverage with Evidence Development: applications and issues. Int J Technol Assess Health Care 2010. 2679–85.
22. Persson U, Willis M, Odegaard K. A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden. Eur J Health Econ 2010. 11195–203.
23. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003. 3482059–2073.
24. Mohr PE, Tunis SR. Access with evidence development: the US experience. Pharmacoeconomics 2010. 28153–162.
25. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, Hopkins R, Tarride JE, Blackhouse G, Lazzam C, Cohen EA, Goeree R. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007. 3571393–1402.
26. Park BJ, Heo DS, Ahn HS, Lee SM, Lee YH, Kim SY, Kim SS, Han SG, Bae EY, Park DA. Evidence-based healthcare 2009. Seoul: Korean Medical Book Publisher; 364.